Bioventus (BVS) Debt Ratio (2020 - 2026)
Bioventus (BVS) posted Debt Ratio of 0.42 for Q1 2026, down 2.74% on a QoQ basis from 0.43 in Q4 2025, and down 9.4% year-over-year from 0.46 in Q1 2025.
Bioventus (BVS) Debt Ratio (2020 - 2026) Analysis & Trends
Bioventus' Debt Ratio history runs 7 years deep, the most recent figure standing at 0.42 for Q1 2026.
- Quarterly Debt Ratio fell 9.4% year-over-year to 0.42 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.42 (down 9.4% YoY) and the FY2025 annual result came in at 0.43, down 6.73% from the prior year.
- Debt Ratio was 0.42 for Q1 2026 at Bioventus, down from 0.43 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.5 in Q2 2023 and bottomed at 0.3 in Q4 2022.
- A 5-year average of 0.43 and a median of 0.46 in 2025 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2023 — Debt Ratio jumped 63.2% — and 2026, when it dropped 9.4%.
- Bioventus' Debt Ratio stood at 0.3 in 2022, then jumped by 59.87% to 0.49 in 2023, then dropped by 5.31% to 0.46 in 2024, then slipped by 6.73% to 0.43 in 2025, then decreased by 2.74% to 0.42 in 2026.
- Business Quant data shows BVS's Debt Ratio at 0.42 in Q1 2026, 0.43 in Q4 2025, and 0.46 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 0.04 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 0.27 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 0.30 |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 0.30 |
| 10 | Bioventus | 837.84 Mn | 801.99 Mn | 90.77 Mn | 0.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 0.42 |
| Dec 31, 2025 | 0.43 |
| Sep 27, 2025 | 0.46 |
| Jun 28, 2025 | 0.42 |
| Mar 29, 2025 | 0.46 |
| Dec 31, 2024 | 0.46 |
| Sep 28, 2024 | 0.50 |
| Jun 29, 2024 | 0.46 |
| Mar 30, 2024 | 0.49 |
| Dec 31, 2023 | 0.49 |
| Sep 30, 2023 | 0.49 |
| Jul 1, 2023 | 0.46 |
| Apr 1, 2023 | 0.50 |
| Dec 31, 2022 | 0.30 |
| Oct 1, 2022 | 0.30 |
| Jul 2, 2022 | 0.31 |
| Apr 2, 2022 | 0.31 |
| Dec 31, 2021 | 0.29 |
| Oct 2, 2021 | 0.27 |
| Jul 3, 2021 | 0.28 |